Form 4: Sabra Health Care CEO Awarded 99,577 Stock Units

Sabra Health Care REIT's Chair, CEO, and President, Richard K. Matros, was granted 99,577 stock units under the company's performance incentive plan.

Summary

• Richard K. Matros, Chair, CEO, and President of Sabra Health Care REIT, Inc. (SBRA), was granted 99,577 stock units.
• The grant occurred on December 31, 2025, under the Issuer's 2009 Performance Incentive Plan.
• These units vest at a rate of 25% annually on December 31, 2026, December 31, 2027, December 31, 2028, and December 31, 2029.
• Vested units will be paid on a one-for-one basis in shares of Common Stock in the 2030 calendar year, subject to earlier payment upon separation from service, death, disability, or change of control.
• Following this transaction, Matros directly beneficially owns 967,366 stock units and indirectly owns 1,624,750 shares of Common Stock through the R&A Matros Revocable Trust.

Sentiment

Score: 7

Explanation: The grant of stock units to the CEO is a positive signal for long-term alignment of interests between management and shareholders, reflecting a commitment to future performance and stability.

Positives

• The grant of 99,577 stock units to the CEO aligns management's interests with long-term shareholder value.
• The performance incentive plan encourages sustained performance over a multi-year vesting period, extending through 2029 with payment in 2030.

Future Outlook

The vesting schedule for the granted stock units extends through 2029, with payment in 2030, indicating a long-term incentive structure for the CEO designed to align his performance with the company's sustained success.

Industry Context

Form 4 filings are standard for reporting insider transactions. This grant is typical for executive compensation in the REIT sector, aligning leadership's long-term interests with the performance of the company's assets and overall shareholder value.

Comparison to Industry Standards

• Executive equity grants are a common compensation practice across the REIT sector and broader public companies, designed to incentivize long-term performance and align management interests with shareholders.
• The multi-year vesting schedule (25% annually over four years) is standard for such performance-based awards, promoting sustained leadership and strategic execution.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the CEO's interests with long-term company performance and shareholder value creation.
• Employees: No direct impact mentioned, but a stable leadership team with long-term incentives can contribute to overall company stability and strategic direction.

Next Steps

• Vesting of 25% of stock units on December 31, 2026.
• Vesting of 25% of stock units on December 31, 2027.
• Vesting of 25% of stock units on December 31, 2028.
• Vesting of 25% of stock units on December 31, 2029.
• Payment of vested units in shares of Common Stock in the 2030 calendar year.

Key Dates

Recommendation

This Form 4 reports a routine grant of stock units to the CEO as part of his compensation package, which is a standard practice to align executive incentives with long-term shareholder value. It does not present new information that would fundamentally alter the investment thesis for Sabra Health Care REIT, Inc., thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Sabra Health Care REIT, SBRA, Form 4, stock grant, executive compensation, insider transaction, Richard K. Matros, stock units, performance incentive plan